How many FDA warning letters has Glenmark Pharmaceuticals Inc., USA received?

Argus HQ has not recorded an FDA warning letter for Glenmark Pharmaceuticals Inc., USA in our current dataset.

What FDA recalls has Glenmark Pharmaceuticals Inc., USA issued?

Argus HQ has recorded 1 FDA recall tied to Glenmark Pharmaceuticals Inc., USA.

Is Glenmark Pharmaceuticals Inc., USA FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Glenmark Pharmaceuticals Inc., USA. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

Glenmark Pharmaceuticals Inc., USA

Name: FDA Enforcement Actions Against Glenmark Pharmaceuticals Inc., USA
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_recall · drug_recall2026-06-24
Glenmark Pharmaceuticals Inc., USA — Class II recall: Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0…

Frequently asked questions

How many FDA warning letters has Glenmark Pharmaceuticals Inc., USA received?: Argus HQ has not recorded an FDA warning letter for Glenmark Pharmaceuticals Inc., USA in our current dataset.
What FDA recalls has Glenmark Pharmaceuticals Inc., USA issued?: Argus HQ has recorded 1 FDA recall tied to Glenmark Pharmaceuticals Inc., USA.
Is Glenmark Pharmaceuticals Inc., USA FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Glenmark Pharmaceuticals Inc., USA. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.